RE:Underappreciated Gem, Competition Won't Be Able to Compete Both Willow and InMed should do well in the coming year. I'm curious to see how their processes will be different. InMed's Integrasyn will be GMP batch ready in Q4 but their model is slightly different in that they intend to license out their cannabinoid manufacturing process instead producing mass quantities themselves.